J. Merriman

发表

Normal and pathological serum levels of alpha2-macroglobulins in men and mice.

K. James, I. Milne, A. Tunstall, 1975, Journal of clinical pathology.

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

N. Agarwal, W. Samlowski, Sumati Gupta, 2016, Ecancermedicalscience.

Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.

N. Agarwal, J. Tward, D. Albertson, 2016, Journal of immunotherapy.

Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.

W. McBride, K. James, I. Milne, 1979, British Journal of Cancer.

Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.

R. Kavlock, R. Setzer, C. Lau, 2001, Toxicological sciences : an official journal of the Society of Toxicology.

A comparison of 1- and 2-cell ova production by F2 50% Meishan versus F1 White line gilts.

J. Keirns, M. J. Martin, C. Merriman, 1993, Theriogenology.

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

N. Agarwal, V. Thodima, J. Houldsworth, 2019, PloS one.

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2

N. Agarwal, B. Redman, A. Alva, 2016, Cancer Immunology, Immunotherapy.

Serum alpha 2-macroglobulin levels in diabetes.

K. James, R. Herd, R. Gray, 1980, Journal of clinical pathology.

Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue

Y. Hitchcock, I. Garrido-Laguna, S. Clardy, 2016, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

Tumour-associated immunoglobulins and host cell infiltration

R. Cullen, K. James, K. Moore, 1981, Cancer Immunology, Immunotherapy.

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

N. Agarwal, D. Albertson, D. Stenehjem, 2017, BMC Urology.

Tumor-associated immunoglobulins, antitumor antibodies, and antiviral antibodies in C. parvum-treated normal and tumor-bearing mice

J. Ihle, W. McBride, K. James, 1978, Cancer Immunology, Immunotherapy.

Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.

K. James, J. Merriman, S. Davis, 1993, Environmental health perspectives.

Association of host immunoglobulins with solid tumours in vivo.

K. James, J. Merriman, Y. H. Bessos, 1979, British Journal of Cancer.

Extension of overall survival (OS) beyond objective responses (OR) in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with high dose interleukin-2 (HD IL-2).

N. Agarwal, B. Redman, A. Alva, 2015 .